Global Platelet Aggregation Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global platelet aggregation devices market size reached US$ 525.0 Million in 2022. Looking forward, the market is expected to reach US$ 744.7 Million by 2028, exhibiting a growth rate (CAGR) of 6.00% during 2022-2028.

Platelet aggregation devices comprise adenosine-diphosphate (ADP), thrombin, and ristocetin-induced platelet aggregation (RIPA). These devices are used to diagnose patients with inherited and acquired platelet function disorders, such as excessive bleeding, arterial thrombotic, stroke, and myocardial infarction. They assist in transfusing medicines, pre-surgery tests, and clinical settings to monitor the response of antiplatelet therapies and assess perioperative bleeding risk. At present, due to the launch of new potential biomarkers and technologies, platelet aggregation devices are finding extensive application in personalizing antiplatelet drugs and monitoring the efficacy of various types of pro-hemostatic therapies around the world.

Platelet Aggregation Devices Market Trends

The rising instances of platelet aggregation among patients diagnosed with coronavirus disease (COVID-19) are strengthening the growth of the market. Moreover, due to the growing prevalence of colon cancer, cardiovascular diseases, Kawasaki condition, acute coronary syndrome (ACS), acute ischemic stroke, and acute rheumatic disorders across the globe, there is an increase in the risk of bleeding. This acts as another key factor impelling the growth of the platelet aggregation devices market for clinical management of platelet function disorders. In addition, a significant rise in the aging population suffering from chronic diseases is contributing to the market growth. Apart from this, leading manufacturers are launching novel products to expand their product portfolio and retain a competitive edge in the market. They are also focusing on developing new and simpler point-of-care (POC) diagnostic devices. These devices rely on the latest methodologies for helping in the rapid evaluation of inherited and acquired bleeding disorders and antiplatelet therapies. This, coupled with the increasing need for POC diagnostic devices to fulfill the healthcare demand of the large population, is projected to drive the market.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global platelet aggregation devices market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, type, application and end user.

Breakup by Product:

• Systems
• Reagents
• Consumables and Accessories

Breakup by Type:

• Four Channel
• Dual Channel
• Eight Channel

Breakup by Application:

• Clinical Applications
• Research Applications
• Cardiovascular Applications
• Orthopedic Applications

Breakup by End User:

• Hospitals
• Diagnostic Laboratories
• Research and Academic Institutes

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Latin America
• Brazil
• Mexico
• Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aggredyne Inc., Chrono-Log Corporation, F. Hoffmann-La Roche AG, Grifols S.A., Hart Biologicals Ltd., Helena Laboratories Corporation, LAbor BioMedical Technologies GmbH, Matis Medical Inc., Sentinel Ch. S.P.A., Siemens AG, Sienco Inc., Sysmex Corporation and WerfenLife SA.

Key Questions Answered in This Report

1. What was the size of the global platelet aggregation devices market in 2022?
2. What is the expected growth rate of the global platelet aggregation devices market during 2023-2028?
3. What has been the impact of COVID-19 on the global platelet aggregation devices market?
4. What are the key factors driving the global platelet aggregation devices market?
5. What is the breakup of the global platelet aggregation devices market based on the product?
6. What is the breakup of the global platelet aggregation devices market based on the type?
7. What is the breakup of the global platelet aggregation devices market based on the application?
8. What is the breakup of the global platelet aggregation devices market based on the end user?
9. What are the key regions in the global platelet aggregation devices market?
10. Who are the key players/companies in the global platelet aggregation devices market?